GLESSNER COLEEN (EVP, Quality & Ethics, and CPL) reported 1 transaction at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/10/2026ACC: 0001919170-26-000016
Officer· EVP, Quality & Ethics, and CPL
Since Mar 2022
-2.02K
Net shares
Net seller
$16.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.02K
Price / share
$8.00
Trade value
$16.14K
% of position
1.0%
6/8/2026
204.22K→202.20K
Total
Net shares
−2.02K
Net value
-$16.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2026 | F · Tax Withholding | −2.02K | $8.00 | $16.14K | 1.0% | 204.22K | 202.20K |
| Total | −2.02K | -$16.14K | ||||||
Derivative Transactions0
No derivative transactions reported